(ERAS) Erasca - Performance -33.6% in 12m
ERAS performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-84.72%
#153 in Peer-Group
Rel. Strength
14.93%
#6529 in Stock-Universe
Total Return 12m
-33.64%
#104 in Peer-Group
Total Return 5y
-91.74%
#123 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 3.28 USD |
| 52 Week Low | 1.06 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 64.26 |
| Buy/Sell Signal +-5 | 0.29 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ERAS (-33.6%) vs XBI (-7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.23% | 73% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.1% | -6.38% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
3.91% | -0.97% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.34% | 27.6% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.69% | -7.17% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
18.3% | 43% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.03% | 58.7% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.2% | 28.7% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: ERAS vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ERAS
| Total Return (including Dividends) | ERAS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -5.88% | 3.36% | 5.25% |
| 3 Months | 24.14% | 15.73% | 24.13% |
| 12 Months | -33.64% | -7.02% | 14.15% |
| 5 Years | -91.74% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | ERAS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -74.7% | 4.4% | 81% |
| 3 Months | 45.6% | 78.8% | 96.9% |
| 12 Months | -83.5% | -85.8% | 44.9% |
| 5 Years | -89.4% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th36.50 | -8.94% | -10.57% |
| 3 Month | %th57.00 | 7.26% | 0.01% |
| 12 Month | %th48.00 | -28.63% | -41.87% |
| 5 Years | %th40.50 | -87.82% | -94.61% |
FAQs
Does Erasca (ERAS) outperform the market?
No,
over the last 12 months ERAS made -33.64%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.02%.
Over the last 3 months ERAS made 24.14%, while XBI made 15.73%.
Performance Comparison ERAS vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ERAS vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 8.2% | -11.1% | -51.7% | -48% |
| US NASDAQ 100 | QQQ | 8.4% | -11.2% | -52.4% | -46% |
| German DAX 40 | DAX | 10.4% | -4.5% | -63.9% | -63% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 8.4% | -9.1% | -55.2% | -54% |
| Hongkong Hang Seng | HSI | 8.6% | -11.9% | -71.2% | -72% |
| India NIFTY 50 | INDA | 10.1% | -9.4% | -52.1% | -33% |
| Brasil Bovespa | EWZ | 5.8% | -14.7% | -76.8% | -44% |
ERAS vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 9.6% | -11.8% | -55.9% | -58% |
| Consumer Discretionary | XLY | 8.7% | -9.1% | -44.1% | -52% |
| Consumer Staples | XLP | 7.9% | -6.5% | -53.4% | -43% |
| Energy | XLE | 7.9% | -12.9% | -47.6% | -33% |
| Financial | XLF | 7.5% | -11% | -56.7% | -64% |
| Health Care | XLV | 8.8% | -8% | -44.4% | -29% |
| Industrial | XLI | 8.1% | -10.1% | -59.6% | -59% |
| Materials | XLB | 6% | -10.2% | -56.3% | -40% |
| Real Estate | XLRE | 8.3% | -6.9% | -51.5% | -46% |
| Technology | XLK | 7.5% | -14.6% | -54.1% | -45% |
| Utilities | XLU | 9.3% | -7.7% | -55% | -57% |
| Aerospace & Defense | XAR | 10.3% | -12.9% | -70.3% | -83% |
| Biotech | XBI | 7.2% | -9.2% | -38.5% | -27% |
| Homebuilder | XHB | 5.7% | -12.9% | -44.6% | -39% |
| Retail | XRT | 5.7% | -10.9% | -47.4% | -45% |
ERAS vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 7.3% | -14.3% | -43.3% | -26% |
| Natural Gas | UNG | 17.7% | 3.9% | -34.9% | -31% |
| Gold | GLD | 8% | -4.7% | -72.4% | -73% |
| Silver | SLV | 7.2% | -12.8% | -69.1% | -51% |
| Copper | CPER | 9.2% | -10.5% | -68.8% | -45% |
ERAS vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 10% | -6.9% | -48.3% | -32% |
| iShares High Yield Corp. Bond | HYG | 9.4% | -7.5% | -50.6% | -44% |